Financhill
Back

Craneware PLC Quote, Financials, Valuation and Earnings

Craneware PLC Price Quote

$27.80

Craneware PLC Key Stats

Sell
50
Craneware PLC (CRWRF) is a Sell

Day range:
$27.80 - $27.80
52-week range:
$20.00 - $30.00
Dividend yield:
1.33%
P/E ratio:
82.99
P/S ratio:
5.18
P/B ratio:
3%

Volume:
0
Avg. volume:
35
1-year change:
39%
Market cap:
$984.4M
Revenue:
$189.3M
EPS:
$0.33

How Much Does Craneware PLC Make?

Is Craneware PLC Growing As A Company?

Data Unavailable

Craneware PLC Stock Price Performance

  • Did Craneware PLC Stock Go Up Last Month?
    Craneware PLC share price went up by 13.42% last month
  • Did CRWRF's Share Price Rise Over The Last Year?
    CRWRF share price rose by 39% over the past 1 year

What Is Craneware PLC 52-Week High & Low?

Craneware PLC Price To Free Cash Flow

Is It Risky To Buy Craneware PLC?

  • How Much Debt Does Craneware PLC Have?
    Total long term debt quarterly is $35.4M
  • How Much Cash Does Craneware PLC Have?
    Cash and short term investments quarterly total is $34.6M
  • What Is Craneware PLC’s Book Value Per Share?
    Book value per share is 9.30

Is Craneware PLC Cash Flow Positive?

  • What Is CRWRF Cash Flow From Operations?
    Cash flow from operations (TTM) is $41.9M
  • What Is Craneware PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$70M
  • What Is Craneware PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$15.8M

Craneware PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    CRWRF return on invested capital is 3.03%
  • What Is Craneware PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 2.07%
  • What Is CRWRF Return On Equity?
    ROE is a measure of profitability and is 3.58%

Craneware PLC Earnings Date & Stock Price

Craneware PLC Competitors

  • Who Are Craneware PLC's Competitors?
    Below is a list of companies who compete with Craneware PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • Verona Pharma PLC (VRNA)

Craneware PLC Dividend Yield

Craneware PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CRWRF shares are owned by institutional investors?
    12M CRWRF shares are owned by institutional investors
  • How many CRWRF shares are owned by insiders?
    0 CRWRF shares are owned by insiders